Q2 FY26 results with USD 24M Africa investment and Income Tax notice update
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 2.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Akums reported Q2 and H1 FY26 results. Consolidated revenue was flat at Rs 2,041 crore while profit after tax fell 16 percent to Rs 107 crore. Standalone PAT dropped 26 percent. Board approved a USD 24 million (Rs 200 crore) staggered investment in a new Zambia subsidiary for African manufacturing. Auditors flagged as Emphasis of Matter an Income Tax search from January 2025 - a Section 158BC notice has been received with returns being filed. Report has no qualifications.
Soft profits but USD 24M Africa expansion plan underway; unresolved Income Tax matter remains a key risk.